Project: Arterial spin labelling Scanner- and Patient-Independent Robust diagnostic Evaluation
| Acronym | ASPIRE (Reference Number: 113701) |
| Duration | 01/05/2020 - 01/01/2024 |
| Project Topic | ASPIRE will create a novel imaging biomarker for dementia for diagnosis support. Signs of Alzheimer’s (AD) will be detectable at early stages before clinical manifestation. The solution is based on the non-invasive magnetic resonance imaging (MRI) technique “Arterial Spin Labelling” (ASL) combined with scanner calibration, physiological atlas comparison, and artificial intelligence (AI)-based diagnostic support. The technique will simplify the diagnostic process, reduce cost and patient risk. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 12 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Amsterdam UMC, Locatie VUmc | Partner | Netherlands |
| 2 | GOLD STANDARD PHANTOMS LIMITED | Partner | United Kingdom |
| 3 | mediri GmbH | Coordinator | Germany |
| 4 | University of Applied Sciences Darmstadt | Partner | Germany |